[HTML][HTML] Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma
Objective: O6methylguanine-DNA methyltransferase (MGMT) promoter methylation is a
biomarker widely used to predict the sensitivity of IDH-wildtype glioblastoma to …
biomarker widely used to predict the sensitivity of IDH-wildtype glioblastoma to …
Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma
R Chai, G Li, Y Liu, K Zhang, Z Zhao… - Cancer biology & …, 2021 - pubmed.ncbi.nlm.nih.gov
Objective O6methylguanine-DNA methyltransferase (MGMT) promoter methylation is a
biomarker widely used to predict the sensitivity of IDH-wildtype glioblastoma to …
biomarker widely used to predict the sensitivity of IDH-wildtype glioblastoma to …
Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma
R Chai, G Li, Y Liu, K Zhang, Z Zhao, F Wu, Y Chang… - 2021 - search.proquest.com
Objective: O6methylguanine-DNA methyltransferase (MGMT) promoter methylation is a
biomarker widely used to predict thesensitivity of IDH-wildtype glioblastoma to …
biomarker widely used to predict thesensitivity of IDH-wildtype glioblastoma to …
Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma.
R Chai, G Li, Y Liu, K Zhang, Z Zhao, F Wu… - Cancer Biology & …, 2021 - europepmc.org
Objective O6methylguanine-DNA methyltransferase (MGMT) promoter methylation is a
biomarker widely used to predict the sensitivity of IDH-wildtype glioblastoma to …
biomarker widely used to predict the sensitivity of IDH-wildtype glioblastoma to …
[PDF][PDF] Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma
R Chai, G Li, Y Liu, K Zhang, Z Zhao, F Wu, Y Chang… - 2021 - pdfs.semanticscholar.org
Objective: O6methylguanine-DNA methyltransferase (MGMT) promoter methylation is a
biomarker widely used to predict the sensitivity of IDH-wildtype glioblastoma to …
biomarker widely used to predict the sensitivity of IDH-wildtype glioblastoma to …
Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma
R Chai, G Li, Y Liu, K Zhang, Z Zhao… - Cancer Biology & …, 2021 - cancerbiomed.org
Objective: O6methylguanine-DNA methyltransferase (MGMT) promoter methylation is a
biomarker widely used to predict the sensitivity of IDH-wildtype glioblastoma to …
biomarker widely used to predict the sensitivity of IDH-wildtype glioblastoma to …
Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma.
R Chai, G Li, Y Liu, K Zhang, Z Zhao… - Cancer Biology & …, 2021 - search.ebscohost.com
Objective: O6methylguanine-DNA methyltransferase (MGMT) promoter methylation is a
biomarker widely used to predict the sensitivity of IDH-wildtype glioblastoma to …
biomarker widely used to predict the sensitivity of IDH-wildtype glioblastoma to …
[PDF][PDF] Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma
R Chai, G Li, Y Liu, K Zhang, Z Zhao, F Wu, Y Chang… - 2021 - cancerbiomed.org
Objective: O6methylguanine-DNA methyltransferase (MGMT) promoter methylation is a
biomarker widely used to predict the sensitivity of IDH-wildtype glioblastoma to …
biomarker widely used to predict the sensitivity of IDH-wildtype glioblastoma to …